Score Study Report 12: Development of venous collaterals in the Score Study.

Barbara Blodi // Michael Ip // Publications // Feb 01 2013

PubMed ID: 22972448

Author(s): Weinberg DV, Wahle AE, Ip MS, Scott IU, VanVeldhuisen PC, Blodi BA; SCORE Study Investigator Group. Score Study Report 12: Development of venous collaterals in the Score Study. Retina. 2013 Feb;33(2):287-95. doi: 10.1097/IAE.0b013e318263d106. PMID 22972448

Journal: Retina (Philadelphia, Pa.), Volume 33, Issue 2, Feb 2013

PURPOSE To investigate the prevalence of venous collaterals after branch and central retinal vein occlusion, assess the association of venous collaterals with other clinical features (including visual acuity), and determine if treatment with intravitreal corticosteroids influences the development of new venous collaterals.

METHODS Review of data from two multicenter randomized clinical trials in the Standard of Care versus COrticosteroid for REtinal Vein Occlusion (SCORE) Study.

RESULTS Statistically significant associations of venous collaterals and visual acuity at baseline or at follow-up were not found. Treatment with intravitreal triamcinolone acetonide did not appear to influence the development of venous collaterals.

CONCLUSION In contrast to some previous reports, development of venous collaterals did not demonstrate an independent association with visual acuity in eyes with branch retinal vein occlusion or central retinal vein occlusion in the SCORE Study. Intravitreal steroid effects do not appear to influence the development of venous collaterals.